Global Fertility Test

Fertility Test Comprehensive Study by Type (Male Fertility Test {Sperm Tests, Others}, Female Fertility Test {Ultrasound Scan, Hormone Testing, Others}), Application (Hospitals, Clinics, Households), Mode of Purchase (Non-Prescription/OTC-Based, Prescription-Based) Players and Region - Global Market Outlook to 2030

Fertility Test Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 8%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Fertility Test Market Overview:
Fertility tests are conducted on people of reproductive age who have problems conceiving. It is an essential part of fertility evaluation and treatment. Fertility testing involves both partners. According to the American Society of Reproductive Medicine, one-third of infertility cases are due to female factor infertility, one-third are due to male factor infertility, and the remaining third are due to problems on both sides or unexplained infertility. Changing lifestyle and rising obesity rates is causing a rise in infertility rates, thus propelling the market for fertility tests. As per latest study released by AMA Research, the Global Fertility Test market is expected to see growth rate of 8.0%

AttributesDetails
Study Period2018-2030
Base Year2023
Forecast Period2024-2030
Historical Period2018-2023
UnitValue (USD Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


Market Growth Drivers:
Increasing Age of First Time Pregnancies Leading To Increased Risk of Infertility and Increased Prevalence of Infertility Causes Such As Ovulatory Disorders and Tubal Damage

Challenges:
Complex Processes Involved

Restraints:
High Cost of Tests and Equipment

Opportunities:
Increasing Obesity Worldwide Causing Declining Fertility Rates, Cultural Shifts Leading to Increased Acceptance Likely To Raise Demand and Growing Awareness and Ease of Availability Will Boost the Market

Competitive Landscape:
The Market is completely competitive and local and foreign business and concentrating introducing new products to the competitiveness.
Some of the key players profiled in the report are Ava Science Inc. (Switzerland), Babystart Ltd. (United Kingdom), Biozhena Corporation (United States), Church & Dwight (United States), Fairhaven Health (United States), Fertility Focus (United Kingdom), Geratherm Medical AG (Germany), Hilin Life Products (United States), Gregory Pharmaceutical (United Kingdom) and Sensiia (United Kingdom). Additionally, following companies can also be profiled that are part of our coverage like Swiss Precision Diagnostics (SPD) (United Kingdom), Taidoc (Taiwan), Advacare Pharma (China), UEBE Medical GmbH (Germany) and Valley Electronics (Switzerland). Analyst at AMA Research see United States Players to retain maximum share of Global Fertility Test market by 2030. Considering Market by Mode of Purchase, the sub-segment i.e. Non-Prescription/OTC-Based will boost the Fertility Test market.

Latest Market Insights:
In May 2021, Ro, announced the acquisition of Modern Fertility, one of the fastest growing companies in women’s health.This acquisition, one of the largest deals in women’s health tech yet, will accelerate Ro’s position as a leader in women’s health and bring Modern Fertility’s fertility tests and reproductive health tools to our vertically integrated primary care platform.

In January 2022, Kindbody, a leading fertility and family-building care company, today announced the launch of Kind at Home, its consumer products division to support people across their entire reproductive journey, beginning with simple-to-use at-home fertility hormone tests for both women and men. The Kind at Home fertility test kit provides consumers comprehensive information about their fertility status from the convenience of home with personalized recommendations by Kindbody physicians that can be carried to the patient's virtual or in-person clinic appointment.

The most visible and important Artificial Reproductive and Technology (ART) specific regulation that has been developed in the United States is the Fertility Clinic Success Rate and Certification Act of 1992 (FCSRCA). This law requires that “each ART program shall annually report to the Secretary through the Centers for Disease Control and Prevention (CDC) pregnancy success rates achieved by such program through each assisted reproductive technology and the identity of each embryo laboratory used by such program, and whether the laboratory is certified or has applied for such certification.”

What Can be Explored with the Fertility Test Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Fertility Test Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Fertility Test
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Fertility Test market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Fertility Test market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Fertility Test Equipment Manufacturers, Medical Device Manufacturers, Healthcare Providers, Fertility Test Equipment Distributor & Supplier, Downstream Vendors, Research Institutes and Academic Centers, Contract Research Organizations (CROS), Regulatory & Government Bodies, Fertility Test End-Users and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Male Fertility Test {Sperm Tests, Others}
  • Female Fertility Test {Ultrasound Scan, Hormone Testing, Others}
By Application
  • Hospitals
  • Clinics
  • Households
By Mode of Purchase
  • Non-Prescription/OTC-Based
  • Prescription-Based

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Age of First Time Pregnancies Leading To Increased Risk of Infertility
      • 3.2.2. Increased Prevalence of Infertility Causes Such As Ovulatory Disorders and Tubal Damage
    • 3.3. Market Challenges
      • 3.3.1. Complex Processes Involved
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Fertility Test, by Type, Application, Mode of Purchase and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Fertility Test (Value)
      • 5.2.1. Global Fertility Test by: Type (Value)
        • 5.2.1.1. Male Fertility Test {Sperm Tests, Others}
        • 5.2.1.2. Female Fertility Test {Ultrasound Scan, Hormone Testing, Others}
      • 5.2.2. Global Fertility Test by: Application (Value)
        • 5.2.2.1. Hospitals
        • 5.2.2.2. Clinics
        • 5.2.2.3. Households
      • 5.2.3. Global Fertility Test by: Mode of Purchase (Value)
        • 5.2.3.1. Non-Prescription/OTC-Based
        • 5.2.3.2. Prescription-Based
      • 5.2.4. Global Fertility Test Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Fertility Test (Volume)
      • 5.3.1. Global Fertility Test by: Type (Volume)
        • 5.3.1.1. Male Fertility Test {Sperm Tests, Others}
        • 5.3.1.2. Female Fertility Test {Ultrasound Scan, Hormone Testing, Others}
      • 5.3.2. Global Fertility Test by: Application (Volume)
        • 5.3.2.1. Hospitals
        • 5.3.2.2. Clinics
        • 5.3.2.3. Households
      • 5.3.3. Global Fertility Test by: Mode of Purchase (Volume)
        • 5.3.3.1. Non-Prescription/OTC-Based
        • 5.3.3.2. Prescription-Based
      • 5.3.4. Global Fertility Test Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Fertility Test (Price)
      • 5.4.1. Global Fertility Test by: Type (Price)
  • 6. Fertility Test: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Ava Science Inc. (Switzerland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Babystart Ltd. (United Kingdom)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Biozhena Corporation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Church & Dwight (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Fairhaven Health (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Fertility Focus (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Geratherm Medical AG (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Hilin Life Products (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Gregory Pharmaceutical (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Sensiia (United Kingdom)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Fertility Test Sale, by Type, Application, Mode of Purchase and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Fertility Test (Value)
      • 7.2.1. Global Fertility Test by: Type (Value)
        • 7.2.1.1. Male Fertility Test {Sperm Tests, Others}
        • 7.2.1.2. Female Fertility Test {Ultrasound Scan, Hormone Testing, Others}
      • 7.2.2. Global Fertility Test by: Application (Value)
        • 7.2.2.1. Hospitals
        • 7.2.2.2. Clinics
        • 7.2.2.3. Households
      • 7.2.3. Global Fertility Test by: Mode of Purchase (Value)
        • 7.2.3.1. Non-Prescription/OTC-Based
        • 7.2.3.2. Prescription-Based
      • 7.2.4. Global Fertility Test Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Fertility Test (Volume)
      • 7.3.1. Global Fertility Test by: Type (Volume)
        • 7.3.1.1. Male Fertility Test {Sperm Tests, Others}
        • 7.3.1.2. Female Fertility Test {Ultrasound Scan, Hormone Testing, Others}
      • 7.3.2. Global Fertility Test by: Application (Volume)
        • 7.3.2.1. Hospitals
        • 7.3.2.2. Clinics
        • 7.3.2.3. Households
      • 7.3.3. Global Fertility Test by: Mode of Purchase (Volume)
        • 7.3.3.1. Non-Prescription/OTC-Based
        • 7.3.3.2. Prescription-Based
      • 7.3.4. Global Fertility Test Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Fertility Test (Price)
      • 7.4.1. Global Fertility Test by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Fertility Test: by Type(USD Million)
  • Table 2. Fertility Test Male Fertility Test {Sperm Tests, Others} , by Region USD Million (2018-2023)
  • Table 3. Fertility Test Female Fertility Test {Ultrasound Scan, Hormone Testing, Others} , by Region USD Million (2018-2023)
  • Table 4. Fertility Test: by Application(USD Million)
  • Table 5. Fertility Test Hospitals , by Region USD Million (2018-2023)
  • Table 6. Fertility Test Clinics , by Region USD Million (2018-2023)
  • Table 7. Fertility Test Households , by Region USD Million (2018-2023)
  • Table 8. Fertility Test: by Mode of Purchase(USD Million)
  • Table 9. Fertility Test Non-Prescription/OTC-Based , by Region USD Million (2018-2023)
  • Table 10. Fertility Test Prescription-Based , by Region USD Million (2018-2023)
  • Table 11. South America Fertility Test, by Country USD Million (2018-2023)
  • Table 12. South America Fertility Test, by Type USD Million (2018-2023)
  • Table 13. South America Fertility Test, by Application USD Million (2018-2023)
  • Table 14. South America Fertility Test, by Mode of Purchase USD Million (2018-2023)
  • Table 15. Brazil Fertility Test, by Type USD Million (2018-2023)
  • Table 16. Brazil Fertility Test, by Application USD Million (2018-2023)
  • Table 17. Brazil Fertility Test, by Mode of Purchase USD Million (2018-2023)
  • Table 18. Argentina Fertility Test, by Type USD Million (2018-2023)
  • Table 19. Argentina Fertility Test, by Application USD Million (2018-2023)
  • Table 20. Argentina Fertility Test, by Mode of Purchase USD Million (2018-2023)
  • Table 21. Rest of South America Fertility Test, by Type USD Million (2018-2023)
  • Table 22. Rest of South America Fertility Test, by Application USD Million (2018-2023)
  • Table 23. Rest of South America Fertility Test, by Mode of Purchase USD Million (2018-2023)
  • Table 24. Asia Pacific Fertility Test, by Country USD Million (2018-2023)
  • Table 25. Asia Pacific Fertility Test, by Type USD Million (2018-2023)
  • Table 26. Asia Pacific Fertility Test, by Application USD Million (2018-2023)
  • Table 27. Asia Pacific Fertility Test, by Mode of Purchase USD Million (2018-2023)
  • Table 28. China Fertility Test, by Type USD Million (2018-2023)
  • Table 29. China Fertility Test, by Application USD Million (2018-2023)
  • Table 30. China Fertility Test, by Mode of Purchase USD Million (2018-2023)
  • Table 31. Japan Fertility Test, by Type USD Million (2018-2023)
  • Table 32. Japan Fertility Test, by Application USD Million (2018-2023)
  • Table 33. Japan Fertility Test, by Mode of Purchase USD Million (2018-2023)
  • Table 34. India Fertility Test, by Type USD Million (2018-2023)
  • Table 35. India Fertility Test, by Application USD Million (2018-2023)
  • Table 36. India Fertility Test, by Mode of Purchase USD Million (2018-2023)
  • Table 37. South Korea Fertility Test, by Type USD Million (2018-2023)
  • Table 38. South Korea Fertility Test, by Application USD Million (2018-2023)
  • Table 39. South Korea Fertility Test, by Mode of Purchase USD Million (2018-2023)
  • Table 40. Taiwan Fertility Test, by Type USD Million (2018-2023)
  • Table 41. Taiwan Fertility Test, by Application USD Million (2018-2023)
  • Table 42. Taiwan Fertility Test, by Mode of Purchase USD Million (2018-2023)
  • Table 43. Australia Fertility Test, by Type USD Million (2018-2023)
  • Table 44. Australia Fertility Test, by Application USD Million (2018-2023)
  • Table 45. Australia Fertility Test, by Mode of Purchase USD Million (2018-2023)
  • Table 46. Rest of Asia-Pacific Fertility Test, by Type USD Million (2018-2023)
  • Table 47. Rest of Asia-Pacific Fertility Test, by Application USD Million (2018-2023)
  • Table 48. Rest of Asia-Pacific Fertility Test, by Mode of Purchase USD Million (2018-2023)
  • Table 49. Europe Fertility Test, by Country USD Million (2018-2023)
  • Table 50. Europe Fertility Test, by Type USD Million (2018-2023)
  • Table 51. Europe Fertility Test, by Application USD Million (2018-2023)
  • Table 52. Europe Fertility Test, by Mode of Purchase USD Million (2018-2023)
  • Table 53. Germany Fertility Test, by Type USD Million (2018-2023)
  • Table 54. Germany Fertility Test, by Application USD Million (2018-2023)
  • Table 55. Germany Fertility Test, by Mode of Purchase USD Million (2018-2023)
  • Table 56. France Fertility Test, by Type USD Million (2018-2023)
  • Table 57. France Fertility Test, by Application USD Million (2018-2023)
  • Table 58. France Fertility Test, by Mode of Purchase USD Million (2018-2023)
  • Table 59. Italy Fertility Test, by Type USD Million (2018-2023)
  • Table 60. Italy Fertility Test, by Application USD Million (2018-2023)
  • Table 61. Italy Fertility Test, by Mode of Purchase USD Million (2018-2023)
  • Table 62. United Kingdom Fertility Test, by Type USD Million (2018-2023)
  • Table 63. United Kingdom Fertility Test, by Application USD Million (2018-2023)
  • Table 64. United Kingdom Fertility Test, by Mode of Purchase USD Million (2018-2023)
  • Table 65. Netherlands Fertility Test, by Type USD Million (2018-2023)
  • Table 66. Netherlands Fertility Test, by Application USD Million (2018-2023)
  • Table 67. Netherlands Fertility Test, by Mode of Purchase USD Million (2018-2023)
  • Table 68. Rest of Europe Fertility Test, by Type USD Million (2018-2023)
  • Table 69. Rest of Europe Fertility Test, by Application USD Million (2018-2023)
  • Table 70. Rest of Europe Fertility Test, by Mode of Purchase USD Million (2018-2023)
  • Table 71. MEA Fertility Test, by Country USD Million (2018-2023)
  • Table 72. MEA Fertility Test, by Type USD Million (2018-2023)
  • Table 73. MEA Fertility Test, by Application USD Million (2018-2023)
  • Table 74. MEA Fertility Test, by Mode of Purchase USD Million (2018-2023)
  • Table 75. Middle East Fertility Test, by Type USD Million (2018-2023)
  • Table 76. Middle East Fertility Test, by Application USD Million (2018-2023)
  • Table 77. Middle East Fertility Test, by Mode of Purchase USD Million (2018-2023)
  • Table 78. Africa Fertility Test, by Type USD Million (2018-2023)
  • Table 79. Africa Fertility Test, by Application USD Million (2018-2023)
  • Table 80. Africa Fertility Test, by Mode of Purchase USD Million (2018-2023)
  • Table 81. North America Fertility Test, by Country USD Million (2018-2023)
  • Table 82. North America Fertility Test, by Type USD Million (2018-2023)
  • Table 83. North America Fertility Test, by Application USD Million (2018-2023)
  • Table 84. North America Fertility Test, by Mode of Purchase USD Million (2018-2023)
  • Table 85. United States Fertility Test, by Type USD Million (2018-2023)
  • Table 86. United States Fertility Test, by Application USD Million (2018-2023)
  • Table 87. United States Fertility Test, by Mode of Purchase USD Million (2018-2023)
  • Table 88. Canada Fertility Test, by Type USD Million (2018-2023)
  • Table 89. Canada Fertility Test, by Application USD Million (2018-2023)
  • Table 90. Canada Fertility Test, by Mode of Purchase USD Million (2018-2023)
  • Table 91. Mexico Fertility Test, by Type USD Million (2018-2023)
  • Table 92. Mexico Fertility Test, by Application USD Million (2018-2023)
  • Table 93. Mexico Fertility Test, by Mode of Purchase USD Million (2018-2023)
  • Table 94. Fertility Test Sales: by Type(K Units)
  • Table 95. Fertility Test Sales Male Fertility Test {Sperm Tests, Others} , by Region K Units (2018-2023)
  • Table 96. Fertility Test Sales Female Fertility Test {Ultrasound Scan, Hormone Testing, Others} , by Region K Units (2018-2023)
  • Table 97. Fertility Test Sales: by Application(K Units)
  • Table 98. Fertility Test Sales Hospitals , by Region K Units (2018-2023)
  • Table 99. Fertility Test Sales Clinics , by Region K Units (2018-2023)
  • Table 100. Fertility Test Sales Households , by Region K Units (2018-2023)
  • Table 101. Fertility Test Sales: by Mode of Purchase(K Units)
  • Table 102. Fertility Test Sales Non-Prescription/OTC-Based , by Region K Units (2018-2023)
  • Table 103. Fertility Test Sales Prescription-Based , by Region K Units (2018-2023)
  • Table 104. South America Fertility Test Sales, by Country K Units (2018-2023)
  • Table 105. South America Fertility Test Sales, by Type K Units (2018-2023)
  • Table 106. South America Fertility Test Sales, by Application K Units (2018-2023)
  • Table 107. South America Fertility Test Sales, by Mode of Purchase K Units (2018-2023)
  • Table 108. Brazil Fertility Test Sales, by Type K Units (2018-2023)
  • Table 109. Brazil Fertility Test Sales, by Application K Units (2018-2023)
  • Table 110. Brazil Fertility Test Sales, by Mode of Purchase K Units (2018-2023)
  • Table 111. Argentina Fertility Test Sales, by Type K Units (2018-2023)
  • Table 112. Argentina Fertility Test Sales, by Application K Units (2018-2023)
  • Table 113. Argentina Fertility Test Sales, by Mode of Purchase K Units (2018-2023)
  • Table 114. Rest of South America Fertility Test Sales, by Type K Units (2018-2023)
  • Table 115. Rest of South America Fertility Test Sales, by Application K Units (2018-2023)
  • Table 116. Rest of South America Fertility Test Sales, by Mode of Purchase K Units (2018-2023)
  • Table 117. Asia Pacific Fertility Test Sales, by Country K Units (2018-2023)
  • Table 118. Asia Pacific Fertility Test Sales, by Type K Units (2018-2023)
  • Table 119. Asia Pacific Fertility Test Sales, by Application K Units (2018-2023)
  • Table 120. Asia Pacific Fertility Test Sales, by Mode of Purchase K Units (2018-2023)
  • Table 121. China Fertility Test Sales, by Type K Units (2018-2023)
  • Table 122. China Fertility Test Sales, by Application K Units (2018-2023)
  • Table 123. China Fertility Test Sales, by Mode of Purchase K Units (2018-2023)
  • Table 124. Japan Fertility Test Sales, by Type K Units (2018-2023)
  • Table 125. Japan Fertility Test Sales, by Application K Units (2018-2023)
  • Table 126. Japan Fertility Test Sales, by Mode of Purchase K Units (2018-2023)
  • Table 127. India Fertility Test Sales, by Type K Units (2018-2023)
  • Table 128. India Fertility Test Sales, by Application K Units (2018-2023)
  • Table 129. India Fertility Test Sales, by Mode of Purchase K Units (2018-2023)
  • Table 130. South Korea Fertility Test Sales, by Type K Units (2018-2023)
  • Table 131. South Korea Fertility Test Sales, by Application K Units (2018-2023)
  • Table 132. South Korea Fertility Test Sales, by Mode of Purchase K Units (2018-2023)
  • Table 133. Taiwan Fertility Test Sales, by Type K Units (2018-2023)
  • Table 134. Taiwan Fertility Test Sales, by Application K Units (2018-2023)
  • Table 135. Taiwan Fertility Test Sales, by Mode of Purchase K Units (2018-2023)
  • Table 136. Australia Fertility Test Sales, by Type K Units (2018-2023)
  • Table 137. Australia Fertility Test Sales, by Application K Units (2018-2023)
  • Table 138. Australia Fertility Test Sales, by Mode of Purchase K Units (2018-2023)
  • Table 139. Rest of Asia-Pacific Fertility Test Sales, by Type K Units (2018-2023)
  • Table 140. Rest of Asia-Pacific Fertility Test Sales, by Application K Units (2018-2023)
  • Table 141. Rest of Asia-Pacific Fertility Test Sales, by Mode of Purchase K Units (2018-2023)
  • Table 142. Europe Fertility Test Sales, by Country K Units (2018-2023)
  • Table 143. Europe Fertility Test Sales, by Type K Units (2018-2023)
  • Table 144. Europe Fertility Test Sales, by Application K Units (2018-2023)
  • Table 145. Europe Fertility Test Sales, by Mode of Purchase K Units (2018-2023)
  • Table 146. Germany Fertility Test Sales, by Type K Units (2018-2023)
  • Table 147. Germany Fertility Test Sales, by Application K Units (2018-2023)
  • Table 148. Germany Fertility Test Sales, by Mode of Purchase K Units (2018-2023)
  • Table 149. France Fertility Test Sales, by Type K Units (2018-2023)
  • Table 150. France Fertility Test Sales, by Application K Units (2018-2023)
  • Table 151. France Fertility Test Sales, by Mode of Purchase K Units (2018-2023)
  • Table 152. Italy Fertility Test Sales, by Type K Units (2018-2023)
  • Table 153. Italy Fertility Test Sales, by Application K Units (2018-2023)
  • Table 154. Italy Fertility Test Sales, by Mode of Purchase K Units (2018-2023)
  • Table 155. United Kingdom Fertility Test Sales, by Type K Units (2018-2023)
  • Table 156. United Kingdom Fertility Test Sales, by Application K Units (2018-2023)
  • Table 157. United Kingdom Fertility Test Sales, by Mode of Purchase K Units (2018-2023)
  • Table 158. Netherlands Fertility Test Sales, by Type K Units (2018-2023)
  • Table 159. Netherlands Fertility Test Sales, by Application K Units (2018-2023)
  • Table 160. Netherlands Fertility Test Sales, by Mode of Purchase K Units (2018-2023)
  • Table 161. Rest of Europe Fertility Test Sales, by Type K Units (2018-2023)
  • Table 162. Rest of Europe Fertility Test Sales, by Application K Units (2018-2023)
  • Table 163. Rest of Europe Fertility Test Sales, by Mode of Purchase K Units (2018-2023)
  • Table 164. MEA Fertility Test Sales, by Country K Units (2018-2023)
  • Table 165. MEA Fertility Test Sales, by Type K Units (2018-2023)
  • Table 166. MEA Fertility Test Sales, by Application K Units (2018-2023)
  • Table 167. MEA Fertility Test Sales, by Mode of Purchase K Units (2018-2023)
  • Table 168. Middle East Fertility Test Sales, by Type K Units (2018-2023)
  • Table 169. Middle East Fertility Test Sales, by Application K Units (2018-2023)
  • Table 170. Middle East Fertility Test Sales, by Mode of Purchase K Units (2018-2023)
  • Table 171. Africa Fertility Test Sales, by Type K Units (2018-2023)
  • Table 172. Africa Fertility Test Sales, by Application K Units (2018-2023)
  • Table 173. Africa Fertility Test Sales, by Mode of Purchase K Units (2018-2023)
  • Table 174. North America Fertility Test Sales, by Country K Units (2018-2023)
  • Table 175. North America Fertility Test Sales, by Type K Units (2018-2023)
  • Table 176. North America Fertility Test Sales, by Application K Units (2018-2023)
  • Table 177. North America Fertility Test Sales, by Mode of Purchase K Units (2018-2023)
  • Table 178. United States Fertility Test Sales, by Type K Units (2018-2023)
  • Table 179. United States Fertility Test Sales, by Application K Units (2018-2023)
  • Table 180. United States Fertility Test Sales, by Mode of Purchase K Units (2018-2023)
  • Table 181. Canada Fertility Test Sales, by Type K Units (2018-2023)
  • Table 182. Canada Fertility Test Sales, by Application K Units (2018-2023)
  • Table 183. Canada Fertility Test Sales, by Mode of Purchase K Units (2018-2023)
  • Table 184. Mexico Fertility Test Sales, by Type K Units (2018-2023)
  • Table 185. Mexico Fertility Test Sales, by Application K Units (2018-2023)
  • Table 186. Mexico Fertility Test Sales, by Mode of Purchase K Units (2018-2023)
  • Table 187. Fertility Test: by Type(USD/Units)
  • Table 188. Company Basic Information, Sales Area and Its Competitors
  • Table 189. Company Basic Information, Sales Area and Its Competitors
  • Table 190. Company Basic Information, Sales Area and Its Competitors
  • Table 191. Company Basic Information, Sales Area and Its Competitors
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Fertility Test: by Type(USD Million)
  • Table 199. Fertility Test Male Fertility Test {Sperm Tests, Others} , by Region USD Million (2025-2030)
  • Table 200. Fertility Test Female Fertility Test {Ultrasound Scan, Hormone Testing, Others} , by Region USD Million (2025-2030)
  • Table 201. Fertility Test: by Application(USD Million)
  • Table 202. Fertility Test Hospitals , by Region USD Million (2025-2030)
  • Table 203. Fertility Test Clinics , by Region USD Million (2025-2030)
  • Table 204. Fertility Test Households , by Region USD Million (2025-2030)
  • Table 205. Fertility Test: by Mode of Purchase(USD Million)
  • Table 206. Fertility Test Non-Prescription/OTC-Based , by Region USD Million (2025-2030)
  • Table 207. Fertility Test Prescription-Based , by Region USD Million (2025-2030)
  • Table 208. South America Fertility Test, by Country USD Million (2025-2030)
  • Table 209. South America Fertility Test, by Type USD Million (2025-2030)
  • Table 210. South America Fertility Test, by Application USD Million (2025-2030)
  • Table 211. South America Fertility Test, by Mode of Purchase USD Million (2025-2030)
  • Table 212. Brazil Fertility Test, by Type USD Million (2025-2030)
  • Table 213. Brazil Fertility Test, by Application USD Million (2025-2030)
  • Table 214. Brazil Fertility Test, by Mode of Purchase USD Million (2025-2030)
  • Table 215. Argentina Fertility Test, by Type USD Million (2025-2030)
  • Table 216. Argentina Fertility Test, by Application USD Million (2025-2030)
  • Table 217. Argentina Fertility Test, by Mode of Purchase USD Million (2025-2030)
  • Table 218. Rest of South America Fertility Test, by Type USD Million (2025-2030)
  • Table 219. Rest of South America Fertility Test, by Application USD Million (2025-2030)
  • Table 220. Rest of South America Fertility Test, by Mode of Purchase USD Million (2025-2030)
  • Table 221. Asia Pacific Fertility Test, by Country USD Million (2025-2030)
  • Table 222. Asia Pacific Fertility Test, by Type USD Million (2025-2030)
  • Table 223. Asia Pacific Fertility Test, by Application USD Million (2025-2030)
  • Table 224. Asia Pacific Fertility Test, by Mode of Purchase USD Million (2025-2030)
  • Table 225. China Fertility Test, by Type USD Million (2025-2030)
  • Table 226. China Fertility Test, by Application USD Million (2025-2030)
  • Table 227. China Fertility Test, by Mode of Purchase USD Million (2025-2030)
  • Table 228. Japan Fertility Test, by Type USD Million (2025-2030)
  • Table 229. Japan Fertility Test, by Application USD Million (2025-2030)
  • Table 230. Japan Fertility Test, by Mode of Purchase USD Million (2025-2030)
  • Table 231. India Fertility Test, by Type USD Million (2025-2030)
  • Table 232. India Fertility Test, by Application USD Million (2025-2030)
  • Table 233. India Fertility Test, by Mode of Purchase USD Million (2025-2030)
  • Table 234. South Korea Fertility Test, by Type USD Million (2025-2030)
  • Table 235. South Korea Fertility Test, by Application USD Million (2025-2030)
  • Table 236. South Korea Fertility Test, by Mode of Purchase USD Million (2025-2030)
  • Table 237. Taiwan Fertility Test, by Type USD Million (2025-2030)
  • Table 238. Taiwan Fertility Test, by Application USD Million (2025-2030)
  • Table 239. Taiwan Fertility Test, by Mode of Purchase USD Million (2025-2030)
  • Table 240. Australia Fertility Test, by Type USD Million (2025-2030)
  • Table 241. Australia Fertility Test, by Application USD Million (2025-2030)
  • Table 242. Australia Fertility Test, by Mode of Purchase USD Million (2025-2030)
  • Table 243. Rest of Asia-Pacific Fertility Test, by Type USD Million (2025-2030)
  • Table 244. Rest of Asia-Pacific Fertility Test, by Application USD Million (2025-2030)
  • Table 245. Rest of Asia-Pacific Fertility Test, by Mode of Purchase USD Million (2025-2030)
  • Table 246. Europe Fertility Test, by Country USD Million (2025-2030)
  • Table 247. Europe Fertility Test, by Type USD Million (2025-2030)
  • Table 248. Europe Fertility Test, by Application USD Million (2025-2030)
  • Table 249. Europe Fertility Test, by Mode of Purchase USD Million (2025-2030)
  • Table 250. Germany Fertility Test, by Type USD Million (2025-2030)
  • Table 251. Germany Fertility Test, by Application USD Million (2025-2030)
  • Table 252. Germany Fertility Test, by Mode of Purchase USD Million (2025-2030)
  • Table 253. France Fertility Test, by Type USD Million (2025-2030)
  • Table 254. France Fertility Test, by Application USD Million (2025-2030)
  • Table 255. France Fertility Test, by Mode of Purchase USD Million (2025-2030)
  • Table 256. Italy Fertility Test, by Type USD Million (2025-2030)
  • Table 257. Italy Fertility Test, by Application USD Million (2025-2030)
  • Table 258. Italy Fertility Test, by Mode of Purchase USD Million (2025-2030)
  • Table 259. United Kingdom Fertility Test, by Type USD Million (2025-2030)
  • Table 260. United Kingdom Fertility Test, by Application USD Million (2025-2030)
  • Table 261. United Kingdom Fertility Test, by Mode of Purchase USD Million (2025-2030)
  • Table 262. Netherlands Fertility Test, by Type USD Million (2025-2030)
  • Table 263. Netherlands Fertility Test, by Application USD Million (2025-2030)
  • Table 264. Netherlands Fertility Test, by Mode of Purchase USD Million (2025-2030)
  • Table 265. Rest of Europe Fertility Test, by Type USD Million (2025-2030)
  • Table 266. Rest of Europe Fertility Test, by Application USD Million (2025-2030)
  • Table 267. Rest of Europe Fertility Test, by Mode of Purchase USD Million (2025-2030)
  • Table 268. MEA Fertility Test, by Country USD Million (2025-2030)
  • Table 269. MEA Fertility Test, by Type USD Million (2025-2030)
  • Table 270. MEA Fertility Test, by Application USD Million (2025-2030)
  • Table 271. MEA Fertility Test, by Mode of Purchase USD Million (2025-2030)
  • Table 272. Middle East Fertility Test, by Type USD Million (2025-2030)
  • Table 273. Middle East Fertility Test, by Application USD Million (2025-2030)
  • Table 274. Middle East Fertility Test, by Mode of Purchase USD Million (2025-2030)
  • Table 275. Africa Fertility Test, by Type USD Million (2025-2030)
  • Table 276. Africa Fertility Test, by Application USD Million (2025-2030)
  • Table 277. Africa Fertility Test, by Mode of Purchase USD Million (2025-2030)
  • Table 278. North America Fertility Test, by Country USD Million (2025-2030)
  • Table 279. North America Fertility Test, by Type USD Million (2025-2030)
  • Table 280. North America Fertility Test, by Application USD Million (2025-2030)
  • Table 281. North America Fertility Test, by Mode of Purchase USD Million (2025-2030)
  • Table 282. United States Fertility Test, by Type USD Million (2025-2030)
  • Table 283. United States Fertility Test, by Application USD Million (2025-2030)
  • Table 284. United States Fertility Test, by Mode of Purchase USD Million (2025-2030)
  • Table 285. Canada Fertility Test, by Type USD Million (2025-2030)
  • Table 286. Canada Fertility Test, by Application USD Million (2025-2030)
  • Table 287. Canada Fertility Test, by Mode of Purchase USD Million (2025-2030)
  • Table 288. Mexico Fertility Test, by Type USD Million (2025-2030)
  • Table 289. Mexico Fertility Test, by Application USD Million (2025-2030)
  • Table 290. Mexico Fertility Test, by Mode of Purchase USD Million (2025-2030)
  • Table 291. Fertility Test Sales: by Type(K Units)
  • Table 292. Fertility Test Sales Male Fertility Test {Sperm Tests, Others} , by Region K Units (2025-2030)
  • Table 293. Fertility Test Sales Female Fertility Test {Ultrasound Scan, Hormone Testing, Others} , by Region K Units (2025-2030)
  • Table 294. Fertility Test Sales: by Application(K Units)
  • Table 295. Fertility Test Sales Hospitals , by Region K Units (2025-2030)
  • Table 296. Fertility Test Sales Clinics , by Region K Units (2025-2030)
  • Table 297. Fertility Test Sales Households , by Region K Units (2025-2030)
  • Table 298. Fertility Test Sales: by Mode of Purchase(K Units)
  • Table 299. Fertility Test Sales Non-Prescription/OTC-Based , by Region K Units (2025-2030)
  • Table 300. Fertility Test Sales Prescription-Based , by Region K Units (2025-2030)
  • Table 301. South America Fertility Test Sales, by Country K Units (2025-2030)
  • Table 302. South America Fertility Test Sales, by Type K Units (2025-2030)
  • Table 303. South America Fertility Test Sales, by Application K Units (2025-2030)
  • Table 304. South America Fertility Test Sales, by Mode of Purchase K Units (2025-2030)
  • Table 305. Brazil Fertility Test Sales, by Type K Units (2025-2030)
  • Table 306. Brazil Fertility Test Sales, by Application K Units (2025-2030)
  • Table 307. Brazil Fertility Test Sales, by Mode of Purchase K Units (2025-2030)
  • Table 308. Argentina Fertility Test Sales, by Type K Units (2025-2030)
  • Table 309. Argentina Fertility Test Sales, by Application K Units (2025-2030)
  • Table 310. Argentina Fertility Test Sales, by Mode of Purchase K Units (2025-2030)
  • Table 311. Rest of South America Fertility Test Sales, by Type K Units (2025-2030)
  • Table 312. Rest of South America Fertility Test Sales, by Application K Units (2025-2030)
  • Table 313. Rest of South America Fertility Test Sales, by Mode of Purchase K Units (2025-2030)
  • Table 314. Asia Pacific Fertility Test Sales, by Country K Units (2025-2030)
  • Table 315. Asia Pacific Fertility Test Sales, by Type K Units (2025-2030)
  • Table 316. Asia Pacific Fertility Test Sales, by Application K Units (2025-2030)
  • Table 317. Asia Pacific Fertility Test Sales, by Mode of Purchase K Units (2025-2030)
  • Table 318. China Fertility Test Sales, by Type K Units (2025-2030)
  • Table 319. China Fertility Test Sales, by Application K Units (2025-2030)
  • Table 320. China Fertility Test Sales, by Mode of Purchase K Units (2025-2030)
  • Table 321. Japan Fertility Test Sales, by Type K Units (2025-2030)
  • Table 322. Japan Fertility Test Sales, by Application K Units (2025-2030)
  • Table 323. Japan Fertility Test Sales, by Mode of Purchase K Units (2025-2030)
  • Table 324. India Fertility Test Sales, by Type K Units (2025-2030)
  • Table 325. India Fertility Test Sales, by Application K Units (2025-2030)
  • Table 326. India Fertility Test Sales, by Mode of Purchase K Units (2025-2030)
  • Table 327. South Korea Fertility Test Sales, by Type K Units (2025-2030)
  • Table 328. South Korea Fertility Test Sales, by Application K Units (2025-2030)
  • Table 329. South Korea Fertility Test Sales, by Mode of Purchase K Units (2025-2030)
  • Table 330. Taiwan Fertility Test Sales, by Type K Units (2025-2030)
  • Table 331. Taiwan Fertility Test Sales, by Application K Units (2025-2030)
  • Table 332. Taiwan Fertility Test Sales, by Mode of Purchase K Units (2025-2030)
  • Table 333. Australia Fertility Test Sales, by Type K Units (2025-2030)
  • Table 334. Australia Fertility Test Sales, by Application K Units (2025-2030)
  • Table 335. Australia Fertility Test Sales, by Mode of Purchase K Units (2025-2030)
  • Table 336. Rest of Asia-Pacific Fertility Test Sales, by Type K Units (2025-2030)
  • Table 337. Rest of Asia-Pacific Fertility Test Sales, by Application K Units (2025-2030)
  • Table 338. Rest of Asia-Pacific Fertility Test Sales, by Mode of Purchase K Units (2025-2030)
  • Table 339. Europe Fertility Test Sales, by Country K Units (2025-2030)
  • Table 340. Europe Fertility Test Sales, by Type K Units (2025-2030)
  • Table 341. Europe Fertility Test Sales, by Application K Units (2025-2030)
  • Table 342. Europe Fertility Test Sales, by Mode of Purchase K Units (2025-2030)
  • Table 343. Germany Fertility Test Sales, by Type K Units (2025-2030)
  • Table 344. Germany Fertility Test Sales, by Application K Units (2025-2030)
  • Table 345. Germany Fertility Test Sales, by Mode of Purchase K Units (2025-2030)
  • Table 346. France Fertility Test Sales, by Type K Units (2025-2030)
  • Table 347. France Fertility Test Sales, by Application K Units (2025-2030)
  • Table 348. France Fertility Test Sales, by Mode of Purchase K Units (2025-2030)
  • Table 349. Italy Fertility Test Sales, by Type K Units (2025-2030)
  • Table 350. Italy Fertility Test Sales, by Application K Units (2025-2030)
  • Table 351. Italy Fertility Test Sales, by Mode of Purchase K Units (2025-2030)
  • Table 352. United Kingdom Fertility Test Sales, by Type K Units (2025-2030)
  • Table 353. United Kingdom Fertility Test Sales, by Application K Units (2025-2030)
  • Table 354. United Kingdom Fertility Test Sales, by Mode of Purchase K Units (2025-2030)
  • Table 355. Netherlands Fertility Test Sales, by Type K Units (2025-2030)
  • Table 356. Netherlands Fertility Test Sales, by Application K Units (2025-2030)
  • Table 357. Netherlands Fertility Test Sales, by Mode of Purchase K Units (2025-2030)
  • Table 358. Rest of Europe Fertility Test Sales, by Type K Units (2025-2030)
  • Table 359. Rest of Europe Fertility Test Sales, by Application K Units (2025-2030)
  • Table 360. Rest of Europe Fertility Test Sales, by Mode of Purchase K Units (2025-2030)
  • Table 361. MEA Fertility Test Sales, by Country K Units (2025-2030)
  • Table 362. MEA Fertility Test Sales, by Type K Units (2025-2030)
  • Table 363. MEA Fertility Test Sales, by Application K Units (2025-2030)
  • Table 364. MEA Fertility Test Sales, by Mode of Purchase K Units (2025-2030)
  • Table 365. Middle East Fertility Test Sales, by Type K Units (2025-2030)
  • Table 366. Middle East Fertility Test Sales, by Application K Units (2025-2030)
  • Table 367. Middle East Fertility Test Sales, by Mode of Purchase K Units (2025-2030)
  • Table 368. Africa Fertility Test Sales, by Type K Units (2025-2030)
  • Table 369. Africa Fertility Test Sales, by Application K Units (2025-2030)
  • Table 370. Africa Fertility Test Sales, by Mode of Purchase K Units (2025-2030)
  • Table 371. North America Fertility Test Sales, by Country K Units (2025-2030)
  • Table 372. North America Fertility Test Sales, by Type K Units (2025-2030)
  • Table 373. North America Fertility Test Sales, by Application K Units (2025-2030)
  • Table 374. North America Fertility Test Sales, by Mode of Purchase K Units (2025-2030)
  • Table 375. United States Fertility Test Sales, by Type K Units (2025-2030)
  • Table 376. United States Fertility Test Sales, by Application K Units (2025-2030)
  • Table 377. United States Fertility Test Sales, by Mode of Purchase K Units (2025-2030)
  • Table 378. Canada Fertility Test Sales, by Type K Units (2025-2030)
  • Table 379. Canada Fertility Test Sales, by Application K Units (2025-2030)
  • Table 380. Canada Fertility Test Sales, by Mode of Purchase K Units (2025-2030)
  • Table 381. Mexico Fertility Test Sales, by Type K Units (2025-2030)
  • Table 382. Mexico Fertility Test Sales, by Application K Units (2025-2030)
  • Table 383. Mexico Fertility Test Sales, by Mode of Purchase K Units (2025-2030)
  • Table 384. Fertility Test: by Type(USD/Units)
  • Table 385. Research Programs/Design for This Report
  • Table 386. Key Data Information from Secondary Sources
  • Table 387. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Fertility Test: by Type USD Million (2018-2023)
  • Figure 5. Global Fertility Test: by Application USD Million (2018-2023)
  • Figure 6. Global Fertility Test: by Mode of Purchase USD Million (2018-2023)
  • Figure 7. South America Fertility Test Share (%), by Country
  • Figure 8. Asia Pacific Fertility Test Share (%), by Country
  • Figure 9. Europe Fertility Test Share (%), by Country
  • Figure 10. MEA Fertility Test Share (%), by Country
  • Figure 11. North America Fertility Test Share (%), by Country
  • Figure 12. Global Fertility Test: by Type K Units (2018-2023)
  • Figure 13. Global Fertility Test: by Application K Units (2018-2023)
  • Figure 14. Global Fertility Test: by Mode of Purchase K Units (2018-2023)
  • Figure 15. South America Fertility Test Share (%), by Country
  • Figure 16. Asia Pacific Fertility Test Share (%), by Country
  • Figure 17. Europe Fertility Test Share (%), by Country
  • Figure 18. MEA Fertility Test Share (%), by Country
  • Figure 19. North America Fertility Test Share (%), by Country
  • Figure 20. Global Fertility Test: by Type USD/Units (2018-2023)
  • Figure 21. Global Fertility Test share by Players 2023 (%)
  • Figure 22. Global Fertility Test share by Players (Top 3) 2023(%)
  • Figure 23. Global Fertility Test share by Players (Top 5) 2023(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Ava Science Inc. (Switzerland) Revenue, Net Income and Gross profit
  • Figure 26. Ava Science Inc. (Switzerland) Revenue: by Geography 2023
  • Figure 27. Babystart Ltd. (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. Babystart Ltd. (United Kingdom) Revenue: by Geography 2023
  • Figure 29. Biozhena Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 30. Biozhena Corporation (United States) Revenue: by Geography 2023
  • Figure 31. Church & Dwight (United States) Revenue, Net Income and Gross profit
  • Figure 32. Church & Dwight (United States) Revenue: by Geography 2023
  • Figure 33. Fairhaven Health (United States) Revenue, Net Income and Gross profit
  • Figure 34. Fairhaven Health (United States) Revenue: by Geography 2023
  • Figure 35. Fertility Focus (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 36. Fertility Focus (United Kingdom) Revenue: by Geography 2023
  • Figure 37. Geratherm Medical AG (Germany) Revenue, Net Income and Gross profit
  • Figure 38. Geratherm Medical AG (Germany) Revenue: by Geography 2023
  • Figure 39. Hilin Life Products (United States) Revenue, Net Income and Gross profit
  • Figure 40. Hilin Life Products (United States) Revenue: by Geography 2023
  • Figure 41. Gregory Pharmaceutical (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 42. Gregory Pharmaceutical (United Kingdom) Revenue: by Geography 2023
  • Figure 43. Sensiia (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 44. Sensiia (United Kingdom) Revenue: by Geography 2023
  • Figure 45. Global Fertility Test: by Type USD Million (2025-2030)
  • Figure 46. Global Fertility Test: by Application USD Million (2025-2030)
  • Figure 47. Global Fertility Test: by Mode of Purchase USD Million (2025-2030)
  • Figure 48. South America Fertility Test Share (%), by Country
  • Figure 49. Asia Pacific Fertility Test Share (%), by Country
  • Figure 50. Europe Fertility Test Share (%), by Country
  • Figure 51. MEA Fertility Test Share (%), by Country
  • Figure 52. North America Fertility Test Share (%), by Country
  • Figure 53. Global Fertility Test: by Type K Units (2025-2030)
  • Figure 54. Global Fertility Test: by Application K Units (2025-2030)
  • Figure 55. Global Fertility Test: by Mode of Purchase K Units (2025-2030)
  • Figure 56. South America Fertility Test Share (%), by Country
  • Figure 57. Asia Pacific Fertility Test Share (%), by Country
  • Figure 58. Europe Fertility Test Share (%), by Country
  • Figure 59. MEA Fertility Test Share (%), by Country
  • Figure 60. North America Fertility Test Share (%), by Country
  • Figure 61. Global Fertility Test: by Type USD/Units (2025-2030)
List of companies from research coverage that are profiled in the study
  • Ava Science Inc. (Switzerland)
  • Babystart Ltd. (United Kingdom)
  • Biozhena Corporation (United States)
  • Church & Dwight (United States)
  • Fairhaven Health (United States)
  • Fertility Focus (United Kingdom)
  • Geratherm Medical AG (Germany)
  • Hilin Life Products (United States)
  • Gregory Pharmaceutical (United Kingdom)
  • Sensiia (United Kingdom)
Additional players considered in the study are as follows:
Swiss Precision Diagnostics (SPD) (United Kingdom) , Taidoc (Taiwan) , Advacare Pharma (China) , UEBE Medical GmbH (Germany) , Valley Electronics (Switzerland)
Select User Access Type

Key Highlights of Report


Jan 2024 224 Pages 87 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Fertility Test Quantitative research analysis
Global Fertility Test Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Fertility Test market are Ava Science Inc. (Switzerland), Babystart Ltd. (United Kingdom), Biozhena Corporation (United States), Church & Dwight (United States), Fairhaven Health (United States), Fertility Focus (United Kingdom), Geratherm Medical AG (Germany), Hilin Life Products (United States), Gregory Pharmaceutical (United Kingdom) and Sensiia (United Kingdom), to name a few.
"" is seen as one of major influencing trends for Fertility Test Market during projected period 2023-2030.
Male Fertility Test {Sperm Tests, Others} segment in Global market to hold robust market share owing to "Increasing Age of First Time Pregnancies Leading To Increased Risk of Infertility ".

Know More About Global Fertility Test Report?

Have a Query? Click Here

Other Related Reports

In-Vitro Diagnostics Comprehensive Study by Type (Reagents & Kits, Instruments (Fully Automated Instruments, Semi-Automated Instruments, and Other Instruments), Data Management Software and Services)...
$ 3750
Pen Needles Comprehensive Study by Type (Safety Pen Needles, Standard Pen Needles), Application (Hospitals, Clinics, Ambulatory Surgical Centres, Other), Therapy (Glucagon-Like Peptide-1 (GLP-1) Ther...
$ 3650
Respiratory Measurement Devices Comprehensive Study by Type (Oral High Frequency Oscillation (OHFO) Device, Intrapulmonary Percussive Ventilation (IPV) Device, Incentive Spirometry (I.S.) Device, Flu...
$ 3650
Meniscal Repair Comprehensive Study by Application (Rotator Cuff Tears, Bicep Tendon Tear, ACL/PCL Injury, Meniscus Tears), Repair Technique (Inside-Out, Outside-In, All-Inside, Root Tears) Players a...
$ 3500
Bioabsorbable Stents Comprehensive Study by Type (Bioresorbable Polymer-Based Stents (Poly-L-Lactic Acid, Polyglycolic Acid, Polycaprolactone), Bioresorbable Metallic Stents (Magnesium, Iron)), Appli...
$ 3650
Ultrasound Machines Comprehensive Study by Type (Stationary Ultrasound, Portable Ultrasound), Application (Radiology & General imaging, Obstetrics & Gynaecology, Cardiology, Urology, Others), Technol...
$ 3750